Neuralink’s First Human Brain Chip Implant Marks a Step Towards Supercharged Abilities and AI Symbiosis.
Promising Milestone: Neuralink Implants Brain Chip in First Human Patient, Elon Musk Reports Positive Initial Results.
Neuralink’s Mission Advances: Creating Direct Brain-Computer Communication Channels, Elon Musk’s Neurotech Vision Unfolds.
Neuralink, co-founded by Elon Musk in 2016, has set ambitious goals centered around enhancing human capabilities, addressing neurological disorders, and fostering a potential symbiotic relationship between humans and artificial intelligence (AI).
Supercharging Human Capabilities: Neuralink aims to enhance human cognitive abilities and overall performance by creating advanced brain-machine interfaces. This could potentially involve improving memory, cognitive processing speed, or even enabling direct communication between individuals and machines.
Elon Musk recently shared on his social media platform, formerly known as Twitter and now referred to as “X,” that the first human recipient of a Neuralink implant underwent the procedure yesterday and is currently recovering successfully.
Elon Musk added that the initial outcomes of the Neuralink implantation are encouraging, indicating successful detection of neuron spikes.
Last year, the startup announced that it had obtained approval from US regulators to conduct tests of its brain implants in human subjects.
Neuralink’s technology primarily operates through an implant known as the “Link.” This device, approximately the size of five stacked coins, is surgically placed inside the human brain.
According to Pitchbook, a data company, Neuralink, based in California, had over 400 employees last year and had successfully secured at least $363 million in funding.
While Elon Musk often grabs the headlines, he is not the sole participant in the pursuit of advancements in the field officially recognized as brain-machine or brain-computer interface research.
Facing delays, Elon Musk has reportedly explored collaboration with implant developer Synchron, indicating a potential investment in the effort to overcome setbacks and advance Neuralink’s goals.
Unlike Neuralink’s Link, the implant developed by Australia-based Synchron doesn’t necessitate cutting into the skull for installation.
Synchron achieved a significant milestone by successfully implanting its first device in a US patient in July 2022.
